Single Use Bioprocessing Market Report 2026

Single Use Bioprocessing Market Overview

• Single Use Bioprocessing market size has reached to $31.94 billion in 2025 • Expected to grow to $81.97 billion in 2030 at a compound annual growth rate (CAGR) of 20.7% • Growth Driver: Surging Demand For Biopharmaceuticals Fuels Growth Of Single-Use Bioprocessing Market • Market Trend: Innovative Solutions Enhance Single-Use Bioprocessing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Single Use Bioprocessing Market?

Single-use bioprocessing refers to bioprocessing equipment designed to be used only once and then discarded. These are generally made of plastic components that are sterilized using gamma radiation. It can help save cleaning time, water, and energy consumption. Single-use bioprocessing is used throughout the bioproduction workflow with the minimum risk of cross-contamination. The main types of products in the single-use bioprocessing market are single-use media bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, and others. Single-use media bags and containers are used for containing sterile media, cell cultures, sera, buffers, and reagents. Single-use media bags and containers are sterile containers that can be only used once and then discarded. The different workflows include upstream, fermentation, and downstream. The various applications are filtration, storage, cell culture, mixing, and purification. It is used by biopharmaceutical and pharmaceutical companies, contract research organizations and contract manufacturing organizations (CROs and CMOs), academic and research institutes.

What Is The Single Use Bioprocessing Market Growth Forecast?

The single use bioprocessing market size is expected to see exponential growth in the next few years. It will grow to $81.97 billion in 2030 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to expansion in large-scale biologics production, adoption in gene and cell therapy, integration with automation and digital monitoring, growth in modular and flexible systems, increasing demand for cost-efficient single-use solutions. Major trends in the forecast period include integration with continuous manufacturing, adoption in vaccine production, rise in modular bioprocessing systems, use in clinical trial production, increasing regulatory compliance for single-use systems.

What Is The Driver Of The Single Use Bioprocessing Market?

The surge in demand for biopharmaceuticals is expected to propel the growth of the single-use bioprocessing market going forward. Biopharmaceuticals are medicines made from living cells or organisms. Single-use bioprocessing systems are commonly used in biopharmaceutical manufacturing for increasing productivity, saving costs, and safe disposal of waste. For instance, in January 2024, according to IQVIA, a US-based provider of biopharmaceutical development services, the spending on global biotech is expected to exceed $892 billion by 2028. Therefore, the increasing demand for biopharmaceuticals is driving the growth of the single-use bioprocessing market.

Key Players In The Global Single Use Bioprocessing Market

Major companies operating in the single use bioprocessing market are GE Healthcare Technologies Ltd, Eppendorf AG, Corning Incorporated, Thermo Fisher Scientific Inc, Sartorius AG, JM BioConnect BV, Merck KGaA, Pall Corporation, PBS Biotech Inc, Entegris Inc, DistriCell Inc, ABEC Inc, Solida Biotech GmbH, OmniBRx Biotechnologies Pvt Ltd, Celltainer Biotech BV, Cellexus BV, Danaher Corporation, Repligen Corporation, Lonza Group Ltd, Meissner Filtration Products Inc, MilliporeSigma, Avantor Performance Materials India Limited, Saint-Gobain Performance Plastics Corp, Rentschler Biopharma SE, Charter Medical Inc, Sollesis Medical Plc, Catalent Inc, Patheon Inc

Global Single Use Bioprocessing Market Trends and Insights

Major companies operating in the single-use bioprocessing market are focused on innovative products such as single-use process container film to gain a competitive advantage and enhance their technology offerings. Ultimus single-use process container film is an innovation integrated into Mobius 3D process containers, offering a remarkable tenfold increase in abrasion resistance compared to other single-use bioprocessing films. For instance, in April 2023, Merck Group, a Germany-based science and technology company, launched Single-Use Process Container Film, a solution aimed at delivering exceptional durability and leak resistance for single-use assemblies applied in bioprocessing liquid applications. The Ultimus film features a unique woven nylon structure, offering enhanced bag strength and improved durability and resilience to mitigate issues such as abrasions, tears, and material fatigue. Ultimus film features an animal-origin-free contact resin with minimal extractables, promoting robust cell growth performance.

What Are Latest Mergers And Acquisitions In The Single Use Bioprocessing Market?

In May 2024, Novo Holdings A/S, a Denmark-based investment company, acquired a 60% majority stake in Single Use Support GmbH for an undisclosed amount. The acquisition allows Novo Holdings to strengthen its manufacturing capabilities and supply chain, particularly as it seeks to support its pharmaceutical subsidiary. Single Use Support GmbH is an Austria-based life sciences tool company providing single-use bioprocessing products.

What Defines the Single Use Bioprocessing Market?

The single-use bioprocessing market includes revenues earned by entities by bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags and containers, mixing systems, tubing assemblies and sampling systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Single Use Bioprocessing Market Report 2026?

The single use bioprocessing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the single use bioprocessing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.